Boston Cons

Boston Cons

Boston Cons

We are a heart health management company. Our goal is to predict, prevent, manage and reverse CVD by improving patient assessment and disease management.
Type
B2b
Founded
2007
Raised
$10M
Follow us
Alexa global traffic share
Acquired by
Eurofins
08 Dec 2014
$140,000,000
Latest funding
$10,000,000
Venture capital (Series C) - 2010
Bain Capital Ventures
Undisclosed amount
Venture capital (Series B) - 2009
Cherrystone Angel Group

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Boston Cons makes some noise.